| Steinwender, Clemens |
| Terminated | 3 | 55 | Europe | Ertugliflozin 5 mg, Steglatro, Placebo 5mg, Sugar pills | Medical University of Graz, Klinikum Klagenfurt am Wörthersee, Elisabethinen Hospital, Medical University Innsbruck, Medical University of Vienna, General Hospital Linz, Landesklinkum Wiener Neustadt, Klinik Ottakring | Heart Failure With Reduced Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy | 06/23 | 10/23 | | |
NCT03505801: Confirm Rx Insertable Cardiac Monitor SMART Registry |
|
|
| Active, not recruiting | N/A | 1826 | Europe, Canada, Japan, US, RoW | Confirm Rx ICM insertion procedure | Abbott Medical Devices | Cardiac Arrhythmias, Symptoms and Signs, Atrial Fibrillation | 09/19 | 03/26 | | |
| Active, not recruiting | N/A | 92 | Europe | Implantation of the Axone 4LV Lead | MicroPort CRM | Heart Failure, Cardiac Resynchronization Therapy | 06/24 | 12/27 | | |
| Recruiting | N/A | 3000 | Europe, Japan, RoW | Cardiac Resynchronization Therapy (CRT) | Biotronik SE & Co. KG | Heart Failure | 03/26 | 03/26 | | |
| Active, not recruiting | N/A | 3326 | Europe, RoW | SELUTION SLR, DES | M.A. Med Alliance S.A. | Coronary Artery Disease | 08/25 | 07/30 | | |
NCT06018818: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family |
|
|
| Active, not recruiting | N/A | 125 | Europe | Amvia/Solvia pacemaker family | Biotronik SE & Co. KG | Bradycardia, Heart Failure | 06/25 | 06/25 | | |
| Recruiting | N/A | 590 | Europe, RoW | Navitor Transcatheter Aortic Valve and FlexNav Delivery System | Abbott Medical Devices | Symptomatic Severe Aortic Stenosis | 06/25 | 02/36 | | |
| Recruiting | N/A | 400 | Europe, US | Arctic Front™ Cardiac Cryoablation Catheter System | Medtronic Cardiac Rhythm and Heart Failure | Persistent Atrial Fibrillation | 08/27 | 08/27 | | |
NCT06048731: Enlighten Study: The EV-ICD Post Approval Registry |
|
|
| Recruiting | N/A | 1000 | Europe, Canada, US, RoW | Defibrillation using EV-ICD | Medtronic | Ventricular Arrhythmia, Tachycardia | 05/30 | 10/37 | | |
| Chun, Julian |
Omega, NCT04829929: Evaluation od Safety and Performance of the ™ LAA (Left Atrial Appendage) Occluder and ™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk |
|
|
| Recruiting | N/A | 150 | Europe | Omega™LAA Occluder implantation | Eclipse Medical Ltd., KCRI | Non-Valvular Atrial Fibrillation | 05/23 | 11/23 | | |
| Recruiting | N/A | 1836 | Europe | Ultrasound guided venous access during AF ablation, Ultrasound | Cardioangiologisches Centrum Bethanien | Puncture for Safe Atrial Fibrillation Ablation | 12/25 | 12/25 | | |
| Recruiting | N/A | 400 | Europe, US | Arctic Front™ Cardiac Cryoablation Catheter System | Medtronic Cardiac Rhythm and Heart Failure | Persistent Atrial Fibrillation | 08/27 | 08/27 | | |
| Beyerbach, Daniel |
| Recruiting | N/A | 400 | Europe, US | Arctic Front™ Cardiac Cryoablation Catheter System | Medtronic Cardiac Rhythm and Heart Failure | Persistent Atrial Fibrillation | 08/27 | 08/27 | | |
| Mahal, Sharan |
| Active, not recruiting | 3 | 9541 | Europe, Canada, Japan, US, RoW | Obicetrapib, Placebo | NewAmsterdam Pharma, Monash University | Atherosclerotic Cardiovascular Disease | 11/26 | 11/26 | | |
| Active, not recruiting | 3 | 14013 | Europe, Canada, US, RoW | Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml | Novartis Pharmaceuticals | Primary Prevention of Atherosclerotic Cardiovascular Disease | 04/29 | 04/29 | | |
| Lampe, Charles |
| Recruiting | N/A | 400 | Europe, US | Arctic Front™ Cardiac Cryoablation Catheter System | Medtronic Cardiac Rhythm and Heart Failure | Persistent Atrial Fibrillation | 08/27 | 08/27 | | |
| Recruiting | N/A | 200 | US | Arctic Front™ Cardiac Cryoablation Catheter | Medtronic Cardiac Rhythm and Heart Failure | Paroxysmal Atrial Fibrillation | 01/28 | 01/28 | | |
